|
Volumn 20, Issue 4, 2002, Pages 480-489
|
Evaluation of cisplatin in combination with a biologic response modifier in a murine mammary carcinoma model
a b a a a b c b b d |
Author keywords
Carcinoma; Cisplatin; Controlled release; Virulizin
|
Indexed keywords
BIOLOGICAL RESPONSE MODIFIER;
CISPLATIN;
UNCLASSIFIED DRUG;
VIRULIZIN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BREAST CARCINOMA;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CONTROLLED RELEASE FORMULATION;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
FLOW CYTOMETRY;
METASTASIS;
MOUSE;
NONHUMAN;
PARTIAL MASTECTOMY;
PRIORITY JOURNAL;
SCORING SYSTEM;
ADENOCARCINOMA;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BILE;
BIOLOGICAL RESPONSE MODIFIERS;
CISPLATIN;
DELAYED-ACTION PREPARATIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
INJECTIONS, INTRAPERITONEAL;
LACTIC ACID;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
MICE, INBRED C3H;
NEOPLASM RECURRENCE, LOCAL;
POLYMERS;
SURVIVAL RATE;
TISSUE EXTRACTS;
|
EID: 0036297241
PISSN: 07357907
EISSN: None
Source Type: Journal
DOI: 10.1081/CNV-120002148 Document Type: Article |
Times cited : (4)
|
References (30)
|